| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,410,000 |
| Market
Cap: |
14.02(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$197.54 - $413.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 463 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
34 |
| Total Shares Sold |
1,742,072 |
2,404,472 |
3,519,952 |
3,608,378 |
| Total Sell Value |
$699,894,249 |
$883,563,199 |
$1,155,800,595 |
$1,175,475,107 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
39 |
65 |
82 |
89 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Troendle August J. |
CEO |
• • • |
2021-08-23 |
4 |
AS |
$180.22 |
$267,086 |
I/I |
(1,482) |
6,048,997 |
|
20% |
|
| Troendle August J. |
CEO |
• • • |
2021-08-18 |
4 |
AS |
$180.49 |
$415,307 |
I/I |
(2,301) |
6,050,479 |
|
24% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-08-18 |
4 |
AS |
$180.49 |
$415,307 |
D/D |
(2,301) |
6,050,479 |
|
24% |
|
| Troendle August J. |
CEO |
• • • |
2021-08-17 |
4 |
AS |
$182.10 |
$955,297 |
I/I |
(5,246) |
6,052,780 |
|
22% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-08-17 |
4 |
AS |
$182.10 |
$955,297 |
D/D |
(5,246) |
6,052,780 |
|
22% |
|
| Troendle August J. |
CEO |
• • • |
2021-08-16 |
4 |
AS |
$182.83 |
$3,074,652 |
I/I |
(16,817) |
6,058,026 |
|
23% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-08-16 |
4 |
AS |
$182.83 |
$3,074,652 |
D/D |
(16,817) |
6,058,026 |
|
23% |
|
| Troendle August J. |
CEO |
• • • |
2021-08-05 |
4 |
AS |
$180.04 |
$100,102 |
I/I |
(556) |
6,074,843 |
|
12% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-08-05 |
4 |
AS |
$180.04 |
$100,102 |
D/D |
(556) |
6,074,843 |
|
12% |
|
| Keating Ashley M. |
Director |
– • – |
2021-08-04 |
4 |
S |
$178.00 |
$178,000 |
D/D |
(1,000) |
0 |
|
-16% |
|
| Keating Ashley M. |
Director |
– • – |
2021-08-04 |
4 |
OE |
$54.99 |
$54,990 |
D/D |
1,000 |
1,000 |
|
- |
|
| Brady Kevin M. |
CFO & TreasurerOfficer |
• – – |
2021-08-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
18% |
|
| King Tom C |
Director |
– • – |
2021-07-29 |
4 |
S |
$175.74 |
$39,717 |
D/D |
(226) |
274 |
|
-22% |
|
| King Tom C |
Director |
– • – |
2021-07-29 |
4 |
OE |
$75.63 |
$37,815 |
D/D |
500 |
500 |
|
- |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-27 |
4 |
AS |
$180.93 |
$23,702 |
D/D |
(131) |
6,075,399 |
|
20% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-27 |
4 |
AS |
$180.93 |
$23,702 |
I/I |
(131) |
6,075,399 |
|
20% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-26 |
4 |
AS |
$181.47 |
$2,759,977 |
D/D |
(15,209) |
6,075,530 |
|
15% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-26 |
4 |
AS |
$181.47 |
$2,759,977 |
I/I |
(15,209) |
6,075,530 |
|
15% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-23 |
4 |
AS |
$181.21 |
$3,421,607 |
D/D |
(18,882) |
6,090,739 |
|
14% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-23 |
4 |
AS |
$181.21 |
$3,421,607 |
I/I |
(18,882) |
6,090,739 |
|
14% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-22 |
4 |
AS |
$180.63 |
$1,538,245 |
D/D |
(8,516) |
6,109,621 |
|
16% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-22 |
4 |
AS |
$180.63 |
$1,538,245 |
I/I |
(8,516) |
6,109,621 |
|
16% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-21 |
4 |
AS |
$182.42 |
$1,679,359 |
I/I |
(9,206) |
6,118,137 |
|
15% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-21 |
4 |
AS |
$182.42 |
$1,679,359 |
D/D |
(9,206) |
6,118,137 |
|
15% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-20 |
4 |
AS |
$183.06 |
$1,862,819 |
I/I |
(10,176) |
6,127,343 |
|
17% |
|
215 Records found
|
|
Page 6 of 9 |
|
|
6.16 (1.58%) 
